ABT

Abbott Laboratories (ABT), classified in the Health Care sector, has drawn disclosed trading activity from 26 members of Congress across 84 total transactions spanning from September 2019 through June 2026, with purchases outnumbering sales 44 to 39, reflecting a modest net-buying posture over the period. The most active disclosers by trade count include Ro Khanna, Josh Gottheimer, Gil Cisneros, and Jared Moskowitz, and the record shows three bipartisan co-trading clusters, one of which spans both chambers of Congress. In the executive branch, 19 officials have separately disclosed 30 transactions in the same security, with the closest congressional and executive purchases falling two days apart in independent filings — a sequence observable in the public record. The name's breadth across 26 members and its bipartisan clustering across both chambers places it among the more broadly held individual equities in the congressional disclosure record for the Health Care sector.